Format
Sort by
Items per page

Send to

Choose Destination

Best matches for serotonin schizophrenia:

Search results

Items: 1 to 20 of 4159

1.

Reduced Efficacy of d-Amphetamine and 3,4-Methylenedioxymethamphetamine in Inducing Hyperactivity in Mice Lacking the Postsynaptic Scaffolding Protein SHANK1.

Sungur AÖ, Redecker TM, Andres E, Dürichen W, Schwarting RKW, Del Rey A, Wöhr M.

Front Mol Neurosci. 2018 Nov 16;11:419. doi: 10.3389/fnmol.2018.00419. eCollection 2018.

PMID:
30505269
2.

The engagement of brain cytochrome P450 in the metabolism of endogenous neuroactive substrates: a possible role in mental disorders.

Haduch A, Daniel WA.

Drug Metab Rev. 2018 Dec 2:1-41. doi: 10.1080/03602532.2018.1554674. [Epub ahead of print]

PMID:
30501426
3.

Serotonergic neurotransmission manipulation for the understanding of brain development and function: learning from Tph2 genetic models.

Pratelli M, Pasqualetti M.

Biochimie. 2018 Dec 1. pii: S0300-9084(18)30341-9. doi: 10.1016/j.biochi.2018.11.016. [Epub ahead of print] Review.

PMID:
30513372
4.

COMT, 5-HTR2A, and SLC6A4 mRNA Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association With Treatment Outcomes.

Li Z, He Y, Han H, Zhou Y, Ma X, Wang D, Zhou J, Ren H, Yuan L, Tang J, Zong X, Hu M, Chen X.

Front Psychiatry. 2018 Nov 13;9:577. doi: 10.3389/fpsyt.2018.00577. eCollection 2018.

5.

Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies.

Marder S, Fleischhacker WW, Earley W, Lu K, Zhong Y, Németh G, Laszlovszky I, Szalai E, Durgam S.

Eur Neuropsychopharmacol. 2018 Nov 20. pii: S0924-977X(18)30843-5. doi: 10.1016/j.euroneuro.2018.10.008. [Epub ahead of print]

6.

Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia.

Vanover KE, Davis RE, Zhou Y, Ye W, Brašić JR, Gapasin L, Saillard J, Weingart M, Litman RE, Mates S, Wong DF.

Neuropsychopharmacology. 2018 Oct 26. doi: 10.1038/s41386-018-0251-1. [Epub ahead of print]

PMID:
30449883
7.

Synergistic effect of aripiprazole and escitalopram in increasing serotonin but not norepinephrine neurotransmission in the rat hippocampus.

Ebrahimzadeh M, El Mansari M, Blier P.

Neuropharmacology. 2018 Nov 8;146:12-18. doi: 10.1016/j.neuropharm.2018.11.006. [Epub ahead of print]

PMID:
30414871
8.

Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia.

Crocker CE, Tibbo PG.

Front Pharmacol. 2018 Oct 18;9:1172. doi: 10.3389/fphar.2018.01172. eCollection 2018. Review.

9.

Toxicological findings in suicides - frequency of antidepressant and antipsychotic substances.

Methling M, Krumbiegel F, Hartwig S, Parr MK, Tsokos M.

Forensic Sci Med Pathol. 2018 Nov 5. doi: 10.1007/s12024-018-0041-4. [Epub ahead of print]

PMID:
30397872
10.

Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics.

Cao X, Zhang Y, Chen Y, Qiu Y, Yu M, Xu X, Liu X, Liu BF, Zhang L, Zhang G.

J Med Chem. 2018 Nov 21;61(22):10017-10039. doi: 10.1021/acs.jmedchem.8b01096. Epub 2018 Nov 9.

PMID:
30383372
11.

Ondansetron - a promising adjunctive treatment for persistent schizophrenia.

Kulkarni J, Thomas N, Hudaib AR, Gavrilidis E, Gurvich C.

J Psychopharmacol. 2018 Nov;32(11):1204-1211. doi: 10.1177/0269881118798608. Epub 2018 Oct 25.

PMID:
30359166
12.

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.

Preller KH, Burt JB, Ji JL, Schleifer CH, Adkinson BD, Stämpfli P, Seifritz E, Repovs G, Krystal JH, Murray JD, Vollenweider FX, Anticevic A.

Elife. 2018 Oct 25;7. pii: e35082. doi: 10.7554/eLife.35082.

13.

Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia.

Alladi CG, RajKumar RP, Adithan S, Marie-Claire C, Bellivier F, Shewade DG.

Fundam Clin Pharmacol. 2018 Oct 17. doi: 10.1111/fcp.12424. [Epub ahead of print]

PMID:
30332506
14.

Involvement of 5-HT1A and 5-HT2A Receptors but Not α 2-Adrenoceptors in the Acute Electrophysiological Effects of Cariprazine in the Rat Brain In Vivo.

Herman A, El Mansari M, Adham N, Kiss B, Farkas B, Blier P.

Mol Pharmacol. 2018 Dec;94(6):1363-1370. doi: 10.1124/mol.118.113290. Epub 2018 Oct 15.

PMID:
30322874
15.

Aripiprazole: An FDA Approved Bioactive Compound to treat schizophrenia-A Mini Review.

Kumar A, Singh H, Mishra A, Mishra AK.

Curr Drug Discov Technol. 2018 Oct 8. doi: 10.2174/1570163815666181008151718. [Epub ahead of print]

PMID:
30306873
16.

Translational tests involving non-reward: methodological considerations.

Phillips BU, Lopez-Cruz L, Saksida LM, Bussey TJ.

Psychopharmacology (Berl). 2018 Oct 10. doi: 10.1007/s00213-018-5062-x. [Epub ahead of print] Review.

PMID:
30306228
17.
18.

Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole.

Osuna-Luque J, Rodríguez-Ramos Á, Gámez-Del-Estal MDM, Ruiz-Rubio M.

J Exp Neurosci. 2018 Sep 18;12:1179069518798628. doi: 10.1177/1179069518798628. eCollection 2018.

19.

Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801.

Hámor PU, Šírová J, Páleníček T, Zaniewska M, Bubeníková-Valešová V, Schwendt M.

Pharmacol Biochem Behav. 2018 Dec;175:89-100. doi: 10.1016/j.pbb.2018.09.007. Epub 2018 Sep 18.

PMID:
30240581
20.

Polymorphisms in the human serotonin receptor 1B (HTR1B) gene are associated with schizophrenia: a case control study.

Xia X, Ding M, Xuan JF, Xing JX, Pang H, Wang BJ, Yao J.

BMC Psychiatry. 2018 Sep 19;18(1):303. doi: 10.1186/s12888-018-1849-x.

Supplemental Content

Loading ...
Support Center